Comparative efficacy and safety of glycopyrronium/formoterol fixed-dose combination versus glycopyrronium monotherapy in patients with moderate-to–severe COPD

Comparative efficacy and safety of glycopyrronium/formoterol fixed-dose combination versus glycopyrronium monotherapy in patients with moderate-to–severe COPD

Background: The safety and efficacy of fixed-dose combination (FDC) of glycopyrronium bromide 12.5 μg/formoterol fumarate 12 μg (GB/FF) twice daily as dry powder inhalers (DPIs) compared to glycopyrronium 50 μg monotherapy (GLY) once daily as DPI in subjects with moderate-to-severe chronic obstructi...

Full description

Bibliographic Details
Main Authors: Sundeep Salvi, Manish K Jain, Srikanth Krishnamurthy, Akash Balki, Rahul Kodgule, Monika Tandon, Sagar Bhagat, Sagar Panchal, Nishtha Khatri, Wen Wu, Amol Pendse, Saiprasad Patil, Hanmant Barkate
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Lung India
Subjects:
copd
fixed-dose combination
formoterol fumarate
glycopyrronium
india
lama/laba
Online Access:http://www.lungindia.com/article.asp?issn=0970-2113;year=2022;volume=39;issue=6;spage=517;epage=524;aulast=Salvi

Similar Items

Similar Items